MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Cancer Genomics and Diagnostics
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,811 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,811 works in the cohort · of 4,299,418page 23 of 57

Labels cover 10 of 2,811 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,811 of 2,811 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Genomic Instability and Cancer Metastasis
Christopher A. Maxwell, Cal Roskelley
2014· book· en· Cancer metastasis· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
7
citations
affunlabeled
Trial in progress: A phase 1, multicenter, open-label, dose-exploration and dose-expansion study evaluating the safety, tolerability, pharmacokinetics, and efficacy of AMG650 in subjects with advanced solid tumors.
Ramaswamy Govindan, Amanda Townsend, Kathy D. Miller, Inderjit Mehmi, Yasutoshi Kuboki, Ecaterina E. Dumbrava +9 more
2021· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
7
citations
affno abstractunlabeled
Genomic alterations in circulating tumor DNA (ctDNA) are associated with clinical outcomes in treatment-naive metastatic castration-resistant prostate cancer (mCRPC) patients commencing androgen receptor (AR)-targeted therapy
Alexander W. Wyatt, Matti Annala, Kevin Beja, Sunil Parimi, Gillian Vandekerkhove, Evan W. Warner +7 more
2016· article· en· Annals of Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
fundno affunlabeled
Spatial epitope barcoding reveals subclonal tumor patch behaviors
Xavier Rovira‐Clavé, Alexandros P. Drainas, Sizun Jiang, Yunhao Bai, Maya Baron, Bokai Zhu +5 more
2021· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
Clonal tracking in cancer and metastasis
Syed Mohammed Musheer Aalam, Long Nguyen, Nagarajan Kannan
2023· review· en· Cancer and Metastasis Reviews· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
fundno affunlabeled
Mutation hotspots may not be drug targets
Hannah Carter
2019· letter· en· Science· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
affno abstractunlabeled
385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study
Ana Oaknin, Lucy Gilbert, Anna V. Tinker, Renaud Sabatier, Valentina Boni, David M. O’Malley +4 more
2020· article· en· International Journal of Gynecological Cancer· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
affaboutunlabeled
The National Oncology Program
V. K. Theodore, P. Salter Susan, F.J.W. ten Kate
2009· article· en· Hematology/Oncology and Stem Cell Therapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
afffundno abstractunlabeled
The Globalization of Cooperative Groups
Manuel Valdivieso, Benjamin W. Corn, Janet Dancey, D. Lawrence Wickerham, Laura E. Horvath, Edith A. Perez +5 more
2015· review· en· Seminars in Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
6
citations
← previousnext →

How this was built: Screen · Findings · About